OGT
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit
Also known as: FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1, OGT1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15294
- Gene
- OGT
- Ensembl
- ENSG00000147162
- Chromosome
- X
- Canonical length
- 1046 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
This gene encodes a glycosyltransferase that catalyzes the addition of a single N-acetylglucosamine in O-glycosidic linkage to serine or threonine residues. Since both phosphorylation and glycosylation compete for similar serine or threonine residues, the two processes may compete for sites, or they may alter the substrate specificity of nearby sites by steric or electrostatic effects. The protein contains multiple tetratricopeptide repeats that are required for optimal recognition of substrates. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
1046 residues, UniProt reviewed canonical sequence.
>O15294|OGT
1 MASSVGNVAD STEPTKRMLS FQGLAELAHR EYQAGDFEAA ERHCMQLWRQ EPDNTGVLLL
61 LSSIHFQCRR LDRSAHFSTL AIKQNPLLAE AYSNLGNVYK ERGQLQEAIE HYRHALRLKP
121 DFIDGYINLA AALVAAGDME GAVQAYVSAL QYNPDLYCVR SDLGNLLKAL GRLEEAKACY
181 LKAIETQPNF AVAWSNLGCV FNAQGEIWLA IHHFEKAVTL DPNFLDAYIN LGNVLKEARI
241 FDRAVAAYLR ALSLSPNHAV VHGNLACVYY EQGLIDLAID TYRRAIELQP HFPDAYCNLA
301 NALKEKGSVA EAEDCYNTAL RLCPTHADSL NNLANIKREQ GNIEEAVRLY RKALEVFPEF
361 AAAHSNLASV LQQQGKLQEA LMHYKEAIRI SPTFADAYSN MGNTLKEMQD VQGALQCYTR
421 AIQINPAFAD AHSNLASIHK DSGNIPEAIA SYRTALKLKP DFPDAYCNLA HCLQIVCDWT
481 DYDERMKKLV SIVADQLEKN RLPSVHPHHS MLYPLSHGFR KAIAERHGNL CLDKINVLHK
541 PPYEHPKDLK LSDGRLRVGY VSSDFGNHPT SHLMQSIPGM HNPDKFEVFC YALSPDDGTN
601 FRVKVMAEAN HFIDLSQIPC NGKAADRIHQ DGIHILVNMN GYTKGARNEL FALRPAPIQA
661 MWLGYPGTSG ALFMDYIITD QETSPAEVAE QYSEKLAYMP HTFFIGDHAN MFPHLKKKAV
721 IDFKSNGHIY DNRIVLNGID LKAFLDSLPD VKIVKMKCPD GGDNADSSNT ALNMPVIPMN
781 TIAEAVIEMI NRGQIQITIN GFSISNGLAT TQINNKAATG EEVPRTIIVT TRSQYGLPED
841 AIVYCNFNQL YKIDPSTLQM WANILKRVPN SVLWLLRFPA VGEPNIQQYA QNMGLPQNRI
901 IFSPVAPKEE HVRRGQLADV CLDTPLCNGH TTGMDVLWAG TPMVTMPGET LASRVAASQL
961 TCLGCLELIA KNRQEYEDIA VKLGTDLEYL KKVRGKVWKQ RISSPLFNTK QYTMELERLY
1021 LQMWEHYAAG NKPDHMIKPV EVTESALocalizationUniProt · AlphaFold · HPA
Whether an antibody against OGT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 118 nTPM
Expression across tissuesHPA
Tissue
- spleen: 118 nTPM
- pancreas: 99 nTPM
- ovary: 84 nTPM
- small intestine: 83 nTPM
- cerebellum: 82 nTPM
- fallopian tube: 75 nTPM
Single-cell type
- pdcs: 294 nCPM
- neutrophil progenitors: 291 nCPM
- cardiomyocytes: 285 nCPM
- myonuclei: 272 nCPM
- t-cells: 254 nCPM
- distal convoluted tubule cells: 247 nCPM
Immune cell
- NK-cell: 8.9 nTPM
- naive CD8 T-cell: 7 nTPM
- memory B-cell: 6.9 nTPM
- gdT-cell: 6.8 nTPM
- naive CD4 T-cell: 6.7 nTPM
- MAIT T-cell: 6 nTPM
Brain region
- cerebral cortex: 78 nTPM
- white matter: 68 nTPM
- hippocampal formation: 67 nTPM
- cerebellum: 65 nTPM
- basal ganglia: 62 nTPM
- choroid plexus: 59 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about OGT.
Disease | AllUniProt
Conditions OGT is implicated in, by any mechanism.
- Intellectual developmental disorder, X-linked 106 (XLID106) MIM:300997
Disease | GeneticClinVar
17 pathogenic / likely-pathogenic of 400 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Intellectual disability, X-linked 106
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.08
- gnomAD pLI
- 1
- gnomAD missense Z
- 5.67
- DepMap mean gene effect
- -1.44
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cellular response to glucose stimulus
- chromatin organization
- circadian regulation of gene expression
- hemopoiesis
- mitophagy
- negative regulation of cell migration
- negative regulation of proteasomal ubiquitin-dependent protein catabolic process
- negative regulation of protein ubiquitination
- negative regulation of stem cell population maintenance
- negative regulation of transcription by RNA polymerase II
- negative regulation of transforming growth factor beta receptor signaling pathway
- positive regulation of cold-induced thermogenesis
- positive regulation of DNA-templated transcription
- positive regulation of lipid biosynthetic process
- positive regulation of proteolysis
- positive regulation of stem cell population maintenance
- positive regulation of TORC1 signaling
- positive regulation of transcription by RNA polymerase II
- positive regulation of transcription from RNA polymerase II promoter by glucose
- positive regulation of translation
- protein O-linked glycosylation
- protein processing
- regulation of gluconeogenesis
- regulation of glycolytic process
- regulation of insulin receptor signaling pathway
- regulation of necroptotic process
- regulation of neurotransmitter receptor localization to postsynaptic specialization membrane
- regulation of Rac protein signal transduction
- regulation of synapse assembly
- regulation of transcription by RNA polymerase II
- response to insulin
- response to nutrient
- signal transduction
- negative regulation of non-canonical inflammasome complex assembly
Molecular functions
- acetylglucosaminyltransferase activity
- chromatin DNA binding
- phosphatidylinositol-3,4,5-trisphosphate binding
- protein O-acetylglucosaminyltransferase activity
Cellular components
- cell projection
- cytosol
- glutamatergic synapse
- histone acetyltransferase complex
- mitochondrial membrane
- NSL complex
- nucleoplasm
- nucleus
- plasma membrane
- protein-containing complex
- Sin3-type complex
- protein N-acetylglucosaminyltransferase complex
Protein domainsUniProt · Pfam · InterPro
- Tetratricopeptide-like helical domain superfamily
- Tetratricopeptide repeat
- Tetratricopeptide repeat
- Tetratricopeptide repeat
- TPR repeat
- Tetratricopeptide repeat
- O-GlcNAc transferase, C-terminal
- UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110kDa subunit
- Glycosyl transferase family 41
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of OGT in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OGT as an antibody target. Whether an autoantibody or antibody against OGT could matter depends on whether native OGT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OGT is annotated at the cell surface, where native OGT is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label OGT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...